About Us
What is TRANSCEND-XR?
TRANSCEND-XR is a collaborative project funded by the European Union’s Horizon Europe research and innovation programme (Grant Agreement No. 101214413). It brings together 15 partners from 12 countries to improve the quality of life for adolescent and young adult testicular cancer survivors and to set new standards for digital health in cancer survivorship.
Many survivors experience ongoing physical, emotional, and social challenges long after treatment ends, yet support systems often fall short. TRANSCEND-XR addresses this gap through an innovative extended reality (XR) intervention - co-created with survivors - that educates, empowers, and supports them in navigating life after cancer.
Why This Project Matters
Testicular cancer is one of the most treatable cancers, especially among young men aged 15–39. But survival is just the beginning. Many adolescents and young adults face late effects from treatment, such as fatigue, anxiety, fertility concerns, or body image issues, often without tailored support or guidance.
TRANSCEND-XR is designed to address these unmet needs by offering a testicular cancer survivorship support tool that is:
- Evidence-based
- Immersive
- Co-created with survivors, caregivers, and clinicians
Our goal is to make recovery more informed, connected, and empowering.
What is Extended Reality (XR) in Cancer Care?
Extended Reality (XR) is an umbrella term that includes technologies like Virtual Reality (VR) and Augmented Reality (AR) which are immersive digital tools that can simulate experiences, deliver training, and provide emotional support in powerful, engaging ways.
In TRANSCEND-XR, this technology is being used to:
- Help survivors better understand late effects of treatment
- Support emotional and social recovery
- Enable personalised, interactive learning experiences
- Provide accessible support from the comfort of home
As one of the few Horizon Europe cancer research projects using immersive technology, TRANSCEND-XR helps demonstrate the potential of extended reality in cancer care to deliver real, scalable impact.
Our Goals
TRANSCEND-XR is built around a few clear and impactful goals:
Increase awareness of testicular cancer’s long-term effects
Empower survivors and caregivers with tailored resources
Co-create meaningful digital tools alongside the people who will use them
Support clinical and policy innovation across Europe
Meet the Team
The TRANSCEND-XR consortium consists of 15 partner organisations across 12 countries, representing leading universities, hospitals, technology firms, and research institutes.
Project Partners Include:
- University College Cork (Coordinator), Ireland
- University Medical Center Groningen, The Netherlands
- Tallaght University Hospital, Ireland
- Erasmus University Medical Center Rotterdam, The Netherlands
- The National Cancer Institute of Milan, Italy
- Gustave Roussy Institute, France
- The Royal Marsden NHS Foundation Trust, England
- Queen's University Belfast, Northern Ireland
- Catholic University of Portugal, Portugal
- Comenius University in Bratislava, Slovak Republic
- University of Zagreb School of Medicine, Croatia
- FundtoInnovate Limited, Ireland
- KHORA, Denmark
- PredictBy Research and Consulting S.L., Spain
- Association of European Cancer Leagues, Belgium
These teams work side by side to ensure that science, empathy, and innovation are embedded in everything we do.
CONNECT WITH US
How We Work
TRANSCEND-XR is not just research happening about people, it’s research happening with people.
The project follows a collaborative, ethical process that includes:
Co-Creation: Working with survivors and caregivers to design the XR tool
Development: Building a usable, intuitive intervention
Testing: Evaluating in real-world clinical and home environments
Scale-Up: Sharing the results and expanding access across Europe
This is more than an app or device, it’s a new way to think about recovery.
Our Funding & Ethics
TRANSCEND-XR is funded by the Horizon Europe Research and Innovation programme, under Grant Agreement No. 101214413.
All project activities are carried out under strict ethical standards, including GDPR compliance and informed consent protocols. Our commitment is to put people, especially survivors, at the centre of every decision we make.
TRANSCEND-XR is funded under the European Union, Horizon Europe Research and Innovation programme (grant agreement number: 101214413). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.